John C Rohloff

This inventor holds 28 USPTO granted patents and 7 published patent applications, plus 5 CIPO patents and 9 EPO patents, primarily in Nucleotide Chemistry. Top assignees: Gilead Sciences, Inc., Somalogic, Incorporated, Syntex (u.s.a.) Inc.. Active years: 1993-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John C Rohloff. Retrieved from https://idiyas.com/inventor/john-c-rohloff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 7)

% Patents Active = 89.3

CIPO Patents = 5

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 4.8

ph-index = 11

Forward Citations = 513(Granted Patents)

Location History:

San Mateo, CA (US) (1993)
Palo Alto, CA (US) (1996)
Mountain View, CA (US) (1996 - 2008)
Boulder, CO (US) (2009 - 2021)

Company Filing History:

12 out of 946

Gilead Sciences, Inc.

patents

9 out of 75

Somalogic, Incorporated

5. 1 out of 834,513

Other

patents

Years Active: 1993-2021

Loading Chart...

Areas of Expertise:

Nucleotide Analog

Aptamers

5-Position Modified Pyrimidines

Anti-Proliferative Compounds

Cytidine-5-Carboxamide

Post-Selex Modification

Phosphonate Nucleotide

Heterocyclic Urea

Sulfonamide Compounds

Carbocyclic Compounds

Synthesis Methods

Antibacterial Compounds

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11208663 - Post-selex modification methods (2021-12-28),

2. 10634679 - Compounds and methods for the synthesis of 5-(N-protected-tryptaminocarboxyamide)-2'-deoxyuridine phosphoramidite for incorporation into a nucleic acid (2020-04-28),

3. 10239908 - Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto (2019-03-26),

4. 10221421 - Post-selec modification methods (2019-03-05),

5. 10221207 - 5-position modified pyrimidines and their use (2019-03-05),

6. 9938314 - Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto (2018-04-10),

7. 9701967 - Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions (2017-07-11),

8. 9410156 - Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions (2016-08-09),

9. 9163056 - 5-position modified pyrimidines and their use (2015-10-20),

10. 8293919 - Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds (2012-10-23),

11. 8268802 - Anti-proliferative compounds, compositions, and methods of use thereof (2012-09-18),

12. 8148380 - Antibacterial amide and sulfonamide substituted heterocyclic urea compounds (2012-04-03),

13. 8088754 - Anti-proliferative compounds, compositions, and methods of use thereof (2012-01-03),

14. 7803788 - Prodrugs of phosphonate nucoleotide analogues (2010-09-28),

15. 7553825 - Anti-proliferative compounds, compositions, and methods of use thereof (2009-06-30),

Title: The Inventor John C Rohloff: Pioneering Innovations in Boulder

Introduction: John C Rohloff is a distinguished inventor based in Boulder, Colorado, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: John C Rohloff holds several patents in the areas of renewable energy technologies, sustainable agriculture solutions, and advanced medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, John C Rohloff has established himself as a visionary inventor, with a keen focus on developing solutions that address pressing global challenges. His commitment to excellence and passion for innovation have earned him recognition in the industry.

Collaborations: Throughout his career, John C Rohloff has collaborated with leading research institutions, universities, and industry experts to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful implementation of cutting-edge technologies.

Conclusion: John C Rohloff's dedication to pushing the boundaries of innovation and his relentless pursuit of creating a positive impact on society make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.